TrialBritish journal of cancer2004

Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.

K Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.